Tamil Nadu's Directorate of Drugs Control has ordered inspections of selected hospitals and their attached pharmacies following reports that inpatients are being charged at or near the maximum retail price (MRP) for medicines and supplies that hospitals procure at significantly discounted rates. The directive, issued on 1 October 2025, marks a targeted regulatory push to close the gap between procurement costs and patient billing across the state.

What the Inspections Cover

Inspectors have been tasked with examining purchase invoices, procurement prices, printed MRP, and actual sale prices charged to patients — with particular attention to high-value medicines and injections. The scrutiny extends to medicines, medical devices, and consumables. Any significant price variation, suspected overcharging, or discrepancy in billing records must be documented and supported by relevant paperwork before reports are forwarded to the directorate.

The exercise has been assigned priority status, with a consolidated report required to be submitted to the directorate upon completion. Where pricing violations are confirmed, action will be initiated under the Drugs (Prices Control) Order, 2013, according to S. Gurubharathi, Joint Director of Drugs Control and Controlling Authority-cum-Licensing Authority, who issued both directives.

Crackdown on Prescription Drug Misuse

A separate communication issued alongside the hospital billing directive has directed assistant directors to intensify checks against the unauthorised sale of habit-forming prescription drugs. Reports of misuse of Tapentadol and Nitrazepam were specifically cited as a public health concern requiring stronger surveillance.

Officers have been instructed to conduct surprise inspections at retail and wholesale outlets, focusing on areas where complaints or information about misuse have already been received. During these checks, inspectors must verify valid prescriptions, purchase and sale records, bills, stock positions, and other relevant documents. Special attention has also been directed toward disposable syringes and needles that could be misused or diverted.

Stock Discrepancies Under the Scanner

Any mismatch between physically available stock and entries in official records must be investigated to establish the nature of the discrepancy. Officers have been required to verify inventories rigorously, ensuring that findings are properly documented before being reported upward. Action-taken reports, with supporting documents, must be forwarded to the directorate for further proceedings.

Context and Significance

The directive comes amid longstanding concerns across India about hospitals exploiting the gap between bulk procurement discounts and retail billing to patients. Notably, the Drugs (Prices Control) Order, 2013 provides a legal framework for price regulation, but enforcement has historically been uneven. This exercise signals a more assertive posture by Tamil Nadu's drug regulator, and could set a precedent for similar inspections in other states grappling with the same issue.

How broadly the inspections are carried out — and whether they lead to prosecutions or recoveries for overcharged patients — will determine whether this directive translates into meaningful consumer protection.